Follow the Data Bivalirudin (and Not Heparin Alone) During Percutaneous Coronary Intervention Provides the Best Clinical Outcomes

被引：6
|
作者：
Stone, Gregg W. [1 ]
Mehran, Roxana [2 ,3 ]
Steg, Philippe Gabriel [4 ,5 ]
机构：
[1] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA
[2] Mt Sinai Med Ctr, New York, NY 10029 USA
[3] Cardiovasc Res Fdn, New York, NY USA
[4] Univ Paris Diderot, Sorbonne Paris Cite, Hop Bichat, AP HP,INSERM U 1148,DHU FIRE, Paris, France
[5] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Lung & Heart Inst, Inst Cardiovasc Med & Sci, London, England
来源：
JACC-CARDIOVASCULAR INTERVENTIONS | 2015年 / 8卷 / 01期
关键词：
bivalirudin; heparin; coronary artery disease; percutaneous coronary intervention; ELEVATION MYOCARDIAL-INFARCTION; ABCIXIMAB; STRATEGIES; RISK;
D O I：
10.1016/j.jcin.2014.10.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：225 / 227
页数：3
相关论文
共 50 条
  • [31] The effects of bivalirudin vs heparin on short-term outcomes in patients undergoing percutaneous coronary intervention
    Palla, Mohan
    Briasoulis, Alexandros
    Telila, Tesfaye
    Kondur, Ashok
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 214 : 271 - 275
  • [32] Clinical outcomes with the use of bivalirudin versus unfractionated heparin in octagenarians undergoing percutaneous coronary interventions
    Kesanakurthy, S
    Dangas, GD
    Lasic, Z
    Vagaonescu, T
    Halkin, A
    Qin, Z
    Stone, G
    Moses, JW
    Leon, MB
    Mehran, R
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 11L - 11L
  • [33] Effect of Bivalirudin on length of stay in the recovery area after percutaneous coronary intervention compared with Heparin alone, Heparin plus Abciximab, or Heparin plus Eptifibatide
    Schussler, JM
    Cameron, CS
    Anwar, A
    Donsky, MS
    Johnson, KB
    Vallabhan, RC
    Wischmeyer, JB
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (11): : 1417 - 1419
  • [34] Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral Percutaneous Coronary Intervention
    MacHaalany, Jimmy
    Abdelaal, Eltigani
    Bataille, Yoann
    Plourde, Guillaume
    Duranleau-Gagnon, Pierre
    Larose, Eric
    Dery, Jean-Pierre
    Barbeau, Gerald
    Rinfret, Stephane
    Rodes-Cabau, Josep
    De Larochelliere, Robert
    Roy, Louis
    Costerousse, Olivier
    Bertrand, Olivier F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (12): : 1742 - 1748
  • [35] Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis
    Narayanan, Mahesh Anantha
    Reddy, Yogesh N. V.
    Anugula, Dixitha
    Gujjula, Nagarjuna
    Badheka, Apurva
    Deshmukh, Abhishek
    Kaushik, Manu
    Raveendran, Ganesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B64 - B64
  • [36] Bivalirudin versus unfractionated heparin during percutaneous coronary intervention (vol 359, pg 688, 2008)
    Kastrati, A.
    Neumann, F. J.
    Mehilli, J.
    Byrne, R. A.
    Iijima, R.
    Buttner, H. J.
    Khattab, A. A.
    Schulz, S.
    Blankenship, J. C.
    Pache, J.
    Minners, J.
    Seyfarth, M.
    Graf, I
    Skelding, K. A.
    Dirschinger, J.
    Richardt, G.
    Berger, P. B.
    Schomig, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (09): : 983 - 983
  • [37] Platelet Activity in Primary Percutaneous Coronary Intervention Patients Randomized to Bivalirudin or Heparin
    Venetsanos, Dimitrios
    Swahn, Eva
    Lawesson, Sofia Sederholm
    Gustafsson, Kerstin M.
    Erlinge, David
    Lindahl, Tomas L.
    Alfredsson, Joakim
    CIRCULATION, 2017, 136
  • [38] SAFETY OF HEPARIN COMPARED WITH BIVALIRUDIN IN PATIENTS UNDERGOING TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION
    Bittl, John A.
    Stables, Rod
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1346 - 1346
  • [39] Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?
    Elgendy, Islam Y.
    Capodanno, Davide
    JOURNAL OF THORACIC DISEASE, 2017, 9 (11) : 4305 - 4307
  • [40] Clinical Outcomes of Percutaneous Coronary Intervention using Bivalirudin Versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in the NHLBI Dynamic Registry
    Iqbal, Sohah N.
    Selzer, Faith
    Feit, Frederick
    Glaser, Ruchira
    Mulukutla, Suresh R.
    Wilensky, Robert L.
    Abbott, J. Dawn
    Williams, David O.
    Slater, James
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A66 - A67
12345